Showing results (61-70 of 155) with videos related to
Sort By:
Pageof 16
Oncotarget|November 19, 2016
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemiaNeil E Kay, Paolo Strati, Betsy R LaPlant, et al.Blood|June 27, 2013
Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemiaPaolo Strati, Michael J Keating, William G Wierda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2025
Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell LymphomaNirav N Shah, Alfredo S Colina, Bryon D Johnson, et al.Blood|April 8, 2014
Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLLPaolo Strati, Michael J Keating, Susan M O'Brien, et al.Clinical Lymphoma, Myeloma & Leukemia|February 7, 2025
Perspectives on Current Challenges and Emerging Approaches for Lymphoma Management From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma ConferenceAlexey V Danilov, Craig Sauter, Tycel Phillips, et al.Annals of Hematology|March 2, 2017
Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractionsPaolo Strati, Prithviraj Bose, Lindsey Lyle, et al.Cancer|October 24, 2013
HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemiaPaolo Strati, Hagop Kantarjian, Deborah Thomas, et al.Clinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemiaPaolo Strati, Naval Daver, Farhad Ravandi, et al.Therapeutic Advances in Medical Oncology|February 18, 2026
Gastrointestinal adverse events following brentuximab vedotin and polatuzumab vedotin therapyAndrew G Kuang, Malek Shatila, Jay S Shah, et al.Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.Pageof 16